Alps Group(NASDAQ) ALPS

Current Price$0.49

Market Cap$77.58M

Since IPO (2021)-95%

5 YearN/A

1 YearN/A

1 Month-28%

Alps Group last closing stock price
Metric	Price	Date
Last close	USD 0.47	2026-07-24

Alps Group stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-6.76%	USD 0.50	2026-07-17
1 month	-28.28%	USD 0.65	2026-06-24
3 month	-48.2%	USD 0.90	2026-04-24
Year to date	-46.38%	USD 0.87	2025-12-31
Since inception	-95.27%	USD 9.85	2021-12-23

Alps Group Financials at a Glance

Market Cap

$77.58M

Revenue (TTM)

$3.37M

Net Income (TTM)

-$67.57M

EPS (TTM)

-$0.73

P/E Ratio

-0.64

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Price

$0.49

Volume

Open

$0.49

Price

$0.49

Volume

Open

$0.49

Previous Close

$0.49

Daily Range

$0.49 - $0.49

52-Week Range

$0.45 - $2.90

Estimated Earnings Date

Jun 30, 2026

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Price

$0.49

Volume

Open

$0.49

Previous Close

$0.49

Daily Range

$0.49 - $0.49

52-Week Range

$0.45 - $2.90

Estimated Earnings Date

Jun 30, 2026

ALPS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alps Group

Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Products and Services

Innovative biotechnology research and development
Direct medical care services
Health optimization initiatives for disease prevention

Growth Outlook

Focus on expanding therapeutic solutions in the healthcare sector
Potential for increased market share in biotechnology
Commitment to innovative research may drive future revenue growth

Financial Highlights

Recent quarterly net income of -$828,384, indicating ongoing operational challenges
Trailing twelve months (TTM) revenue of $3,371,037, showcasing potential for recovery
Current ratio of 0.04, highlighting liquidity concerns

Alps Group Inc. is positioned within the biotechnology industry, focusing on innovative solutions that address critical healthcare needs. Despite recent financial challenges, including a negative net income and low liquidity ratios, the company’s commitment to research and development may provide a pathway for future growth. The recent revenue figures suggest that there is potential for recovery, especially as the organization continues to innovate and expand its offerings in the healthcare sector. Investors may find interest in the company's strategic direction and its efforts to enhance healthcare accessibility through advanced therapeutic solutions.

AI Generated • Jul 4, 2026

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Seng Kong Tham, PhD

Website

www.globalinkinvestment.com

Headquarters

Kuala Lumpur, WP 50400, MY

ALPS Financials

Key Financial Metrics (TTM)

Gross Margin

38.60%

Operating Margin

-1983.07%

Net Income Margin

-2004.52%

Return on Equity

922.42%

Return on Capital

-91181.86%

Return on Assets

-3884.16%

Earnings Yield

-1.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$77.58M

Shares Outstanding

166.40M

Volume

Avg. Volume

110.44K

Financials (TTM)

Gross Profit

$1.30M

Operating Income

-$66.85M

EBITDA

-$66.93M

Operating Cash Flow

-$962.42K

Capital Expenditure

$4.00

Free Cash Flow

-$962.42K

Cash & ST Invst.

$357.73K

Total Debt

$5.91M

Alps Group Performance Analysis

Alps Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 0	N/A
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A

Alps Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-03-31	N/A
Q1	2025-03-31	N/A
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A

Alps Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.01	N/A
2022	2022-12-31	USD 0.02	N/A
2023	2023-12-31	USD 0.14	856.7%
2024	2024-12-31	USD -0.17	N/A

Alps Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-03-31	-5779.2%
Q1	2025-03-31	-311.5%
Q2	2025-06-30	-20.0%
Q3	2025-09-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$77.58M

N/A

Market Cap/Employee

$38.79M

N/A

Employees

N/A

Net Income

-$828.39K

-207.7%

EBITDA

-$442.28K

-163.1%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$357.73K

+41.1%

Total Debt

$5.91M

+33.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$5.91M

+33.0%

Return on Assets

-38.84%

N/A

Return on Invested Capital

9.32%

N/A

Free Cash Flow

-$250.26K

-26.4%

Operating Cash Flow

-$250.26K

-26.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OKYOOKYO Pharma Limited

OKYOOKYO Pharma Limited$1.55+4.73%

ARGYFAvanti Helium Corp.

ARGYFAvanti Helium Corp.$0.34+0.00%

CHKRChesapeake Granite Wash Trust

CHKRChesapeake Granite Wash Trust$0.34+3.02%

HGTXUHugoton Royalty Trust

HGTXUHugoton Royalty Trust$0.14-12.50%

EDBLEdible Garden AG Incorporated

EDBLEdible Garden AG Incorporated$3.14+2.61%

GIPRGeneration Income Properties, Inc.

GIPRGeneration Income Properties, Inc.$0.65-12.34%

BNRGBrenmiller Energy Ltd

BNRGBrenmiller Energy Ltd$0.67-14.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

Questions About ALPS

What is the current price of Alps Group?

Alps Group is trading at $0.49 per share.

What is the 52-week range for Alps Group?

Over the past 52 weeks, Alps Group has traded between $0.45 and $2.90.

How much debt does Alps Group have?

As of the most recent reporting period, Alps Group reported total debt of $5.91M.

How much cash does Alps Group have on hand?

Alps Group reported $357.73K in cash and cash equivalents in its most recent financial results.

What is Alps Group’s dividend yield?

Alps Group does not currently have a dividend yield.

Alps Group(NASDAQ) ALPS

Alps Group Financials at a Glance

ALPS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alps Group

ALPS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alps Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALPS

What is the current price of Alps Group?

What is the 52-week range for Alps Group?

How much debt does Alps Group have?

How much cash does Alps Group have on hand?

What is Alps Group’s dividend yield?

Premium Investing Services